Labcorp and Children's Hospital of Philadelphia Announces Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide

Published: 2026-04-13 14:20:55 ET LH

Published on 04/13/2026 at 02:20 pm EDT

Labcorp and Children's Hospital of Philadelphia announced a strategic collaboration to accelerate the discovery, development and nationwide availability of specialized pediatric diagnostics. By combining Children's Hospital of Philadelphia's pediatric research and clinical expertise with Labcorp's national diagnostic infrastructure, scientific capabilities and commercialization expertise, the collaboration aims to expand access to advanced diagnostic testing for children and families across the country. At the core of the collaboration is the creation of a joint pediatric diagnostics innovation pipeline where Children's Hospital of Philadelphia and Labcorp will team up to identify, develop and expand new tests and technologies with a goal of streamlining the path from discovery to national availability.

Pediatric-specific diagnostics deliver more accurate, age-appropriate insights for children by accounting for their unique biology, developmental stages and physiological ranges?factors that traditional adult-oriented tests often overlook. The collaboration will make novel diagnostics available nationwide across key clinical areas, such as oncology, metabolic disease and autoimmune conditions. Together, the organizations will provide clinicians and health systems with cutting-edge pediatric testing?bringing breakthrough diagnostics in cancer, genetics, immune disorders and rare diseases to patients sooner and enabling earlier, more precise diagnoses.